Wednesday, December 5, 2018

Can infectious disease cause mental illness? A resounding: maybe...

One thing that’s always frustrated me about behavioral science (and I’m sure this has frustrated other people) is the lack of a set of clear explanations of the cause of mental illnesses. Many different mechanisms have been proposed historically: Benjamin Rush, one of the forefathers of American medicine, proposed that madness was the result of poor blood flow to the brain; Sigmund Freud suggested it was due to failures to resolve sexual tension in socially appropriate ways; modern medicine places considerable emphasis on the role of changes in neurotransmitter production and activity.

In all likelihood, individual cases may be due to any number of factors given the high prevalence and considerable diversity of symptoms seen among patients treated for psychiatric disorders. However, another curious association is beginning to emerge which links mental health issues to bacterial infections.

A large-scale study from Denmark found that a history of streptococcal throat infections was associated with an increased risk of developing a mental disorder, especially obsessive compulsive disorder or tic disorders such as Tourette’s. In good scientific style, the authors were quick to clarify that these results do not indicate that infections cause mental illness, as there may be an underlying factors (e.g. genetics, environment, etc.) which leaves individuals vulnerable to both infections and mental disorders.

However, there is still reason to believe that infectious diseases may contribute directly to deleterious changes in brain function. Studies have shown that herpes virus can be found in the brains of patients with Alzheimer’s disease. Herpes infection at the skin of the face can creep back along axons of the trigeminal nerve, leading to infection of the brain -- which can sometimes cause a deadly condition known as herpesviral encephalitis. Though this particular mechanism isn’t a likely cause of cases of mental illnesses, it hardly shuts the door on this subject.

Vitamin D deficiency linked more closely to diabetes than obesity


Vitamin D is an important fat-soluble vitamin required by the human body in order to maintain healthy status. Vitamin D is obtained through an assortment of sources, including diet, supplements, and exposure to the sun, where ultraviolet rays from sunlight trigger vitamin D synthesis when they strike the skin (Institute of Medicine Food and Nutrition Board, 2010; Tai, Need, Horowitz, & Chapman, 2008). Vitamin D deficiency can be the result of limited exposure to sunlight, inadequate dietary consumption of vitamin D, inability of the kidneys to convert it to its active form, or insufficient absorption of the digestive tract of vitamin D (Institute of Medicine Food and Nutrition Board, 2010). Both vitamin D deficiency and glucose metabolism disorders like diabetes are on the rise among the general population. Popular news sources all over the internet explosively list off the reasons why we need to catch some rays for that ‘sunshine’ vitamin, but other stories such as one published by Men’s Journal titled “Vitamin D deficiency increases risk for diabetes more than obesity” actually highlight an important recent finding regarding vitamin D’s importance in our bodies, even if it does reduce its credibility talking about scientific findings by including as the article photo a picture of a tanned and shirtless athletic-looking man laying out while soaking up some rays. This story was however based off a 2015 study published in the Journal of Clinical Endocrinology & Metabolism. The scientific article interestingly found that diabetic subjects had lower levels of vitamin D than subjects who did not have diabetes, regardless of their weight, helping to clarify the connection between these 3 variables. The study suggested that vitamin D deficiency and obesity may interact synergistically to heighten the risk of diabetes (Clemente-Postigo et al., 2015).
            Low levels of the active form of Vitamin D in the body have been linked to obesity and diabetes in observational studies. To become active, vitamin D is hydroxylated twice, first in the liver to become 25-hydroxyvitamin D [25(OH)D] and then in the kidney to become physiologically active 1,25-dihydroxyvitamin D [1,25(OH)2D] (Clemente-Postigo et al., 2015). In measuring vitamin D levels in the body, 25(OH)D is used because circulating 1,25(OH)2D are not considered to be an effective indicator for vitamin D status as it does not decrease in levels until the deficiency is severe. Vitamin D is thought to play a role in glucose homeostasis due to its role in stimulating insulin production (Clemente-Postigo et al., 2015; Dutta et al., 2014). Thus, low vitamin D levels have been associated with increased insulin resistance and effects on insulin sensitivity, although the exact mechanisms are not yet understood (Tai et al., 2008). There is, however, evidence that vitamin D affects pancreatic cell function directly through binding to vitamin D receptors there or indirectly through their function regulating extracellular calcium levels and calcium movement through the β-cells of the pancreas.  
The aim of this study was to evaluate levels of active vitamin D based of diabetic status and weight of participants. As stated, 25(OH)D levels were shown to be closely associated to variables related to glucose metabolism, which supported vitamin D deficiency to be more closely related to glucose metabolism disorders than to obesity. There are, however, other recent studies that contradict these results (Clemente-Postigo et al., 2015; Dutta et al., 2014). Further studies are needed to confirm and understand the role of vitamin D and vitamin D receptors in diabetes.

Resources
Clemente-Postigo, M., Muñoz-Garach, A., Serrano, M., Garrido-Sánchez, L., Bernal-López, M. R., Fernández-García, D., … Macías-González, M. (2015). Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: Relationship with obesity and type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 100(4), E591–E595. https://doi.org/10.1210/jc.2014-3016
Dutta, D., Mondal, S. A., Choudhuri, S., Maisnam, I., Hasanoor Reza, A. H., Bhattacharya, B., … Mukhopadhyay, S. (2014). Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: An open label randomized prospective study from Eastern India. Diabetes Research and Clinical Practice, 103(3). https://doi.org/10.1016/j.diabres.2013.12.044
Institute of Medicine Food and Nutrition Board. (2010). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press. Washington, DC.
Tai, K., Need, A. G., Horowitz, M., & Chapman, I. M. (2008). Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition, 24(3), 279–285. https://doi.org/https://doi.org/10.1016/j.nut.2007.11.006

Circadian Rhythms and Fat Metabolism

The increase in obesity rates is posing serious consequences on public health as the increasing need for liver transplantation is unable to supply the demand. It is well understood that obesity results in the accumulation of fat in the liver which can cause an array of health problems such as inflammation, hepatitis and liver failure. This potential increase in the need for liver transplantation calls for an urgent focus on treatment.

Dr. Mitchell Lazar from the University of Pennsylvania’s School of Medicine investigated how drug therapy could be made more effective by looking at specific protein targets. Interestingly, they found that diet-induced obesity (DIO) causes changes in the gene transcription of a protein called, PPAR-alpha, a protein important for the regulation of fatty acid oxidation. Furthermore, DIO was shown to cause changes in the circadian rhythm of the liver thereby causing fatty acid oxidation and synthesis to become synchronous (Guan, 2018). When comparing times of day and fatty oxidation activity, the researchers actually found that the body’s fat burning activity, more specifically, the activity of PPAR-alpha protein activity, peaked around 5 p.m.. Now, in the interest of maximizing the efficacy of lipid-reducing drugs such as fibrates, these drugs were deemed to be most effective when administered at 5 p.m when the activity of PPAR-alpha is at its peak activity as well (Guan et al., 2018). The chronotherapeutic activity of this drug further suggests that the body’s circadian rhythm plays an important role in metabolism even in healthy individuals. This link of metabolism to circadian rhythm raises concerns for individuals who’s circadian rhythms are disrupted such as if you work the night shift or in individuals with sleep disorders. If fat breakdown is affected by one’s circadian rhythm, then this begs the question: does working the night shift increase your likelihood of developing a metabolic disorder?

Guan, D., Xiong, Y., Borck, P. C., Jang, C., Doulias, P., Papazyan, R., . . . Lazar, M. A. (2018). Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes. Cell,174(4). doi:10.1016/j.cell.2018.06.031


University of Pennsylvania School of Medicine. (2018, July 26). Fat production and burning are synchronized in livers of mice with obesity. ScienceDaily. Retrieved December 5, 2018 from www.sciencedaily.com/releases/2018/07/180726162757.htm

Size Matters!


Structure dictates function. We have learned first-hand how this is true throughout our education. For example, we know that if alanine is substituted for a lysine in the active site of an enzyme, that protein will no longer serve its proper function. Haven’t covered that part of biochem review yet (uh oh)? Here’s another example then: it’s going to take you a lot longer to finish your soup with a knife instead of a spoon, right? (No, sipping from the bowl doesn’t count). This statement proved true yet again in a recent study showing that the size of axonal mitochondria is essential in neuronal calcium regulation. In this study, Lewis and colleagues studied axonal mitochondria in pyramidal neurons. Compared to the long and tubular mitochondria of the dendrites, mitochondria in the axon are shorter and spherical. However, the reason behind the differing shape and size between these mitochondria was unknown until recently. Research has studied dendritic mitochondria mainly in the context of neurodegenerative diseases while axonal mitochondria is known to be involved in axonal branching, ATP production (duh, powerhouse!), and calcium buffering. Yet, according to the researchers, no one had investigated the effects of what happens if you manipulate axonal mitochondrial size. So that’s what they did. Researchers downregulated Mitochondrial fission factor (MFF), a gene that controls mitochondrial fission (division). When MFF was turned off in mice, axonal mitochondria significantly increased in size and calcium intake. Increased calcium uptake resulted in decreased neurotransmitter release (remember our dear SNARE hypothesis) and subsequently decreased neuronal activity between neurons. Additionally, this change resulted in decreased axonal branching. Interestingly, the change in size did not change mitochondria’s ability to act as powerhouses, they can do that in their sleep I guess. Ultimately, the investigators showed that mitochondrial size matters and I’m sure they will soon discover even more dynamic mechanisms that these little guys are capable of.


Lewis, T. L., Kwon, S.-K., Lee, A., Shaw, R., & Polleux, F. (2018). MFF-dependent mitochondrial fission regulates presynaptic release and axon branching by limiting axonal mitochondria size. BioRxiv, 276691. https://doi.org/10.1101/276691